Navigation Links
Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting
Date:11/18/2008

o 19 in Washington, DC. Each year SfN provides the premier venue for neuroscientists to share research findings. SfN's annual meeting draws diverse attendees from all over the world.

About NeuroDiscovery

NeuroDiscovery Ltd is an ASX listed speciality neuroscience services provider and drug development company which owns 100% of NeuroSolutions Ltd (ASX Code NDL).

About NeuroSolutions

NeuroSolutions Limited is a profitable service company, which has applied its broad spectrum expertise and drug discovery platforms to become a leading provider of specialised electrophysiological assays to the biopharmaceutical industry. Electrophysiology is a specialised technique which is used to record electrical activity in membranes, cells or tissues. NeuroSolutions' current clients include many established pharmaceutical and biotechnology companies.

In parallel to running its service business, the Company is also exploiting its in-house technologies and expertise for its own internal R&D and has a mature pipeline of programmes underway for the treatment of pain.

During 2008, the Company reported success in a Phase II trial for NSL-101. The Company also successfully completed two Phase I trials for the development compound NSL-043/SD118, in partnership with Sosei Co. Ltd. Both of these trials reported a successful outcome, facilitating further development.

About Sosei

Sosei Group is a leading international biopharmaceutical company with significant expertise in product discovery and development. It has established a reduced risk business model primarily upon identifying new uses for established drugs and exploiting its unique position within Japanese, European and North American pharmaceutical markets by acquiring compounds from, and bringing compounds into, Japan.

For further information about Sosei, please visit

SOURCE Sosei Group Corporation
Copyright©2008 PR Newswire.
All rights reserved

6

GOOD

Page: 1 2 3

Related medicine technology :

1. Sosei Announces Completion of Phase III Trial for NorLevo(R)
2. ViroPharma Announces Presentation of Cinryze(TM) Data in Acute Treatment of Hereditary Angioedema
3. Tibotec Data Presented at ICAAC and HIV9 Follow Key Regulatory Approvals for Anti-HIV Compounds
4. Celladon Announces Presentation of Clinical Data From First-in-Human MYDICAR(R) Trial for Advanced Heart Failure at American Heart Association Scientific Sessions
5. Data From Investigational Use of PROCRIT(R) (Epoetin alfa) Presented at American Society of Nephrology Annual Meeting
6. Portola Announces Data Presentations Relevant to Its Lead Phase II Antithrombotic Compounds at American Heart Association Scientific Sessions 2008
7. Dendreon Presents Integrated Analysis of Clinical Data from NEUVENGE Trials at Chemotherapy Foundation Symposium
8. VIA Pharmaceuticals Announces Conference Call and Webcast to Discuss VIA-2291 Phase 2 Data Presentations at AHA
9. Sunesis Pharmaceuticals Presents Clinical Trial Data of Voreloxin in Patients with Acute Myeloid Leukemia and Ovarian Cancer at the Chemotherapy Foundation Symposium
10. Oramed Pharmaceuticals Chosen to Present Results of GLP-1 Analog Enteral Administration Study at the Diabetes Technology Societys Eighth Annual Meeting (November 13-15, 2008; Bethesda, Maryland)
11. Micromet Presents Data at the 23rd Annual Meeting of the International Society for Biological Therapy of Cancer on the Activity of Human Antibody Adecatumumab against KRAS-mutated Colon Cancer Cells

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...ON, Nov. 20 The United States Cour...ier District Court ruling yesterday, approving a s...ice (AWP) pharmaceutical litigation against AstraZ.../www.newscom.com/cgi-bin/prnh/20080317/AQM144LOGO ...ed consumers who purchased the pharmaceutical gian...
(Date:11/20/2009)...RK, Nov. 20 Medco Health...ng to a transformation in American healthcare thro...lready delivering higher quality clinical care and...making medicine smarter for the benefit of patient...ned how the elements in its strategy enable "Smart...
(Date:11/20/2009)...W YORK, Nov. 20 ,, Reportlinke...is available in its catalogue. ,, India Medica... ,, http://www.reportlinker.com/p0164658/Indi...to-2015.html#utm_source=prnewswire&utm_medium=...n ,, India Medical Equipment Market Analysis a...
Breaking Medicine Technology:U.S. Court of Appeals Upholds AstraZeneca AWP Settlement 2U.S. Court of Appeals Upholds AstraZeneca AWP Settlement 3Medco Reforming Healthcare with 'Smarter Medicine'; Wired, Transformational Pharmacy Model Advances Clinical Quality and Lowers Cost 2Medco Reforming Healthcare with 'Smarter Medicine'; Wired, Transformational Pharmacy Model Advances Clinical Quality and Lowers Cost 3Medco Reforming Healthcare with 'Smarter Medicine'; Wired, Transformational Pharmacy Model Advances Clinical Quality and Lowers Cost 4Medco Reforming Healthcare with 'Smarter Medicine'; Wired, Transformational Pharmacy Model Advances Clinical Quality and Lowers Cost 5Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 2Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 3Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 4Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 5Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 6Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 7Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 8Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 9Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 10Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 11Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 12Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 13Novavax and the NIH Agree to Evaluate a Virus like Particle 28VLP 29 Vaccine Candidate Against the Novel Influenza A 28H1N1 29 Virus 12465 1Novavax and the NIH Agree to Evaluate a Virus like Particle 28VLP 29 Vaccine Candidate Against the Novel Influenza A 28H1N1 29 Virus 12465 2Novavax and the NIH Agree to Evaluate a Virus like Particle 28VLP 29 Vaccine Candidate Against the Novel Influenza A 28H1N1 29 Virus 12465 3Novavax and the NIH Agree to Evaluate a Virus like Particle 28VLP 29 Vaccine Candidate Against the Novel Influenza A 28H1N1 29 Virus 12465 4Recovery Audit Contractor Connolly Healthcare Licenses Milliman Care Guidelines 28R 29 47886 1Recovery Audit Contractor Connolly Healthcare Licenses Milliman Care Guidelines 28R 29 47886 2Recovery Audit Contractor Connolly Healthcare Licenses Milliman Care Guidelines 28R 29 47886 3Isis Pharmaceuticals to Present at Goldman Sachs 30th Annual Global Healthcare Conference 47884 1
...search, Inc. issues a,review on Nventa Biopharmace...romising Therapeutic and Vaccine Candidate for the...mavirus (HPV)." The analyst research is,available ...com ., About Nventa Corporation:, Nventa is deve...f viral,infections and cancer, with a focus on dis...
...en, Inc.,(Nasdaq: SUPG ) today announced that inv...-arm Phase 1b clinical trial of MP470, a novel, or... The trial will evaluate,MP470 in combination with...cluding carboplatin/paclitaxel, carboplatin/etopos... is expected to enroll up to 105,patients at five ...
Other Medicine Technology:Initiation of Coverage Informational Review Issued by Scimitar Equity Research 2SuperGen Reports Initiation of Multi-arm Phase 1b Trial of Novel Tyrosine Kinase Inhibitor 2SuperGen Reports Initiation of Multi-arm Phase 1b Trial of Novel Tyrosine Kinase Inhibitor 3
(Date:11/23/2009)... Since 1996, crop plants genetically modified to ...in insects, yet safe for people, have been planted...popularity of these Bt crops, named after the bact...bility to kill some major pests, allowing farmers ...reducing insecticide sprays. , However, since in...
(Date:11/23/2009)...Study found one more than doubled chances, while b... Nov. 23 (HealthDay News) -- Children whose mother...ead have more than double the risk of having atten...r children, new research shows. , And with expo...aving ADHD soared. Children whose mothers smoked d...
(Date:11/23/2009)...,, DALLAS,Nov.23/PRNewswire/--TheBerylCompani...rservicesforthehealthcareindustry,hasearnedrecogni...dernHealthcare ,theindustry,sleadingtrademagazine....gfirmsbasedonBeryl,s2008businessresults,whichenabl..., Berylattributesthisgrowthtoitsinnovativeproduct...
(Date:11/23/2009)... Information about Oxycod... launched DopeStats.com. The new site is a statist... use rates of Oxycodone in each county in the Unit...e who have used the drug for recreational or medic...FL (PRWEB) November 23, 2009 -- Legal and illegal ...
(Date:11/23/2009)... Summary: People are hire...onalities. Personality assessments give insight in...ormance. The Candidate Potential Report assesses a...summarizes the recommendation for job fit and pote...ybrook, CT (PRWEB) November 23, 2009 -- When does ...
Breaking Medicine News(10 mins):Health News:Insect resistance to Bt crops can be predicted, monitored and managed 2Health News:Smoking During Pregnancy, Lead Exposure Raise ADHD Risk in Kids 2Health News:Smoking During Pregnancy, Lead Exposure Raise ADHD Risk in Kids 3Health News:The Beryl Companies Named One of the 'Top 10 Outsourcing Firms' in Healthcare 2Health News:DopeStats.com Provides Statistics on Oxycodone Abused in Non-Medical Purposes 2Health News:Candidate Potential Report Reduces Risk of Bad Hires 2Health News:Candidate Potential Report Reduces Risk of Bad Hires 3
...lly Residents to Eat Right, Move More and Milk ...ho, May 29 The last decade can be defined by,the ... to go in and out of,fashion like shoulder pads an..., A new campaign crossing the country, the Campai...
...armaceutical Industries,Ltd. (Reuters: SUN.BO, Blo...y sent a letter to Barrie Levitt, M.D., Chairman o...Sheets: TAROF) regarding Taro,s purported,terminat...he merger as per our agreement. We remain,skeptica...
...08 - Children who can read and have good phonetic ...ounds within words may still be poor spellers. In..., Elizabeth Eglinton and Marian Annett, at the Sch...year study was carried out in a cohort of children...
...umers about Urinary Health, CROMWELL, Conn., May ...nary tract infections (UTIs) are the second most c...or more than 8 million doctor visits,each year. On...omen do not realize the signs of a UTI in the firs...
...n Up To Three Times as Many Calories as,Hand-Held,... the Nintendo Wii, are quickly becoming the most c...ainment value, these systems appear to,be helpful ...ACSM)., One of the studies presented today examin...
...ain Stable or Improve in 83% of Patients ...y 29 /PRNewswire-FirstCall/ - Novadaq(R) Technolog...cal imaging and image guidance,systems for the ope...d with the OPTTX(R) System in commercial practice ...
Other Medicine News:Health News:Message to Idaho Residents: Forgo Fad Dieting and Join the Campaign for Healthy Weight 2Health News:Message to Idaho Residents: Forgo Fad Dieting and Join the Campaign for Healthy Weight 3Health News:Sun Pharma Responds to Taro's Purported Termination of Merger Agreement 2Health News:Sun Pharma Responds to Taro's Purported Termination of Merger Agreement 3Health News:Sun Pharma Responds to Taro's Purported Termination of Merger Agreement 4Health News:Sun Pharma Responds to Taro's Purported Termination of Merger Agreement 5Health News:Sun Pharma Responds to Taro's Purported Termination of Merger Agreement 6Health News:Sun Pharma Responds to Taro's Purported Termination of Merger Agreement 7Health News:AZO Answers the Burning Question: What's Up Down There? 2Health News:AZO Answers the Burning Question: What's Up Down There? 3Health News:AZO Answers the Burning Question: What's Up Down There? 4Health News:Kids' Energy Expenditure High in Active Video Games 2Health News:Novadaq Updates on OPTTX Data Reported at Euroretina 2Health News:Novadaq Updates on OPTTX Data Reported at Euroretina 3Health News:Novadaq Updates on OPTTX Data Reported at Euroretina 4
FF 450plus IR
... for fast and easy operation with advanced lens me...utomatically held when the lens is properly aligne...The sophisticated alignment system guides you to c...designed with a small footprint, occupying little ...
CR6-45NM Non-Mydriatic Retinal Camera
TRC-50FXC
Medicine Products: